Truist Securities lowers Astrana Health stock price target to $37 on guidance reset
NeutralFinancial Markets

Truist Securities has lowered its stock price target for Astrana Health to $37 following a reset in guidance. This adjustment reflects changes in the company's outlook and is significant for investors as it may influence market perceptions and trading strategies related to Astrana Health. The revision indicates a cautious approach by Truist Securities, highlighting potential challenges or shifts in the company's performance expectations.
— via World Pulse Now AI Editorial System